Clover Health Investments (CLOV) has shared an announcement.
Clover Health Investments, Corp. has announced the launch of Counterpart Assistant, an expansion of its Clover Assistant platform, now available to external payors and providers. This development marks a significant step in the company’s growth, offering its advanced clinical decision support tool to a broader market, which could have a notable impact on the company’s reach and financial performance in the healthcare sector.
Learn more about CLOV stock on TipRanks’ Stock Analysis page.
